Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display

FASEB Journal

Volumn 27, Issue 10, 2013, Pages 4136-4146

  Yu, Haixiang ^a   Segers, Filip ^a   Sliedregt Bol, Karen ^b   Bot, Ilze ^a   Woltman, Andrea M ^c   Boross, Peter ^c   Verbeek, Sjef ^c   Overkleeft, Herman ^b   Van Der Marel, Gijs A ^b   Van Kooten, Cees ^c   Van Berkel, Theo J C ^a   Biessen, Erik A L ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Autoimmune diseases; CD154

Indexed keywords

ALANINE; APOLIPOPROTEIN E; CD40 LIGAND; INTERLEUKIN 6; NP 31; STREPTAVIDIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; PEPTIDE LIBRARY; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG POTENCY; ENDOTHELIUM CELL; INFLAMMATION; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; TRANSCRIPTION INITIATION; AMINO ACID SEQUENCE; ANIMAL; AORTA; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CELL LINE; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

MURINAE; MUS;

AMINO ACID SEQUENCE; ANIMALS; AORTA; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CD40 LIGAND; CELL LINE; HUMANS; INFLAMMATION; MICE; PEPTIDE LIBRARY; PROTEIN BINDING;

EID: 84885150074     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-224667     Document Type: Article

References (39)

1. Van Kooten, C., and Banchereau, J. (1996) CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61, 1-77
2. Clark, L. B., Foy, T. M., and Noelle, R. J. (1996) CD40 and its ligand. Adv. Immunol. 63, 43-78
3. Grewal, I. S., and Flavell, R. A. (1998) CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135
4. Schonbeck, U., and Libby, P. (2001) CD40 signaling and plaque instability. Circ. Res. 89, 1092-1103
5. Schonbeck, U., and Libby, P. (2001) The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58, 4-43
6. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., and Spriggs, M. K. (1993) CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674
7. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Kiener, P. A., and Aruffo, A. (1995) Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33-40
8. Bruemmer, D., Riggers, U., Holzmeister, J., Grill, M., Settmacher, U., Regitz-Zagrosek, V., Fleck, E., and Graf, K. (2001) Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am. J. Cardiol. 87, 21-27
9. Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., and Pober, J. S. (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U. S. A. 92, 4342-4346
10. Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Stern, D., and Chess, L. (1995) Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182, 1857-1864
11. Mach, F., Schonbeck, U., Sukhova, G. K., Bourcier, T., Pober, J. S., and Libby, P. (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 94, 1931-1936
12. Krzesz, R., Wagner, A. H., Cattaruzza, M., and Hecker, M. (1999) Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1. FEBS Lett. 453, 191-196
13. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L. Noelle, R. J., Ledbetter, J. A., Francke, U., and Ochs, H. D. (1993) The CD40 ligand, gp 39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300
14. Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Boersma, W. J., and Claassen, E. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93, 2499-2504
15. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., and Pearson, T. C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438
16. Lutgens, E., Gorelik, L., Daemen, M. J., De Muinck, E. D., Koteliansky, V. E., and Flavell, R. A. (1999) Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5, 1313-1316
17. Mach, F., Schonbeck, U., Sukhova, G. K., Atkinson, E., and Libby, P. (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394, 200-203
18. Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., and Noelle, R. J. (1993) Prevention of collagen-induced arthritis with an antibody to gp 39, the ligand for CD40. Science 261, 1328-1330
19. Lutgens, E., Cleutjens, K. B., Heeneman, S., Koteliansky, V. E., and Daemen, M. J. (2000) Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. U. S. A. 97, 7464-7469
20. Kyburz, D., Carson, D. A., and Corr, M. (2000) The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheumatism 43, 2571-2577
21. Kawai, T., Andrews, D., Colvin, R. B., Sachs, D. H., and Cosimi, A. B. (2000) Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. 6, 114
22. Tai, Y. T., Podar, K., Gupta, D., Lin, B., Akiyama, M., and Anderson, K. C. (2002) CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells. Blood 99, 1419-1427
23. Wang, N., Gates, K. L., Trejo, H., Favoreto, S., Schleimer, R. P., Sznajder, J. I., Beitel, G. J., and Sporn, P. H. (2010) Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage. FASEB J. 24, 2178-2190
24. Van Kooten, C., Gerritsma, J. S., Paape, M. E., Van Es, L. A., and Daha, M. R. (1997) Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Intl. 51, 711-721
25. Molenaar, T. J., Appeldoorn, C. C., De Haas, S. A., Michon, I. N., Hoylaerts, M. F., Pannekoek, H., Van Berkel, T. J., Kuiper, J., and Biessen, E. A. (2002) Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists. Blood 100, 3570-3577
26. Yu, H., Sliedregt-Bol, K., Overkleeft, H., Van der Marel, G. A., and Biessen, E. A. (2006) Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent. Arterioscler. Thromb. Vasc. Biol. 26, 1531-1537
27. Boross, P., and Verbeek, J. S. (2006) The complex role of Fcgamma receptors in the pathology of arthritis. Springer Semin Immunopathol. 28, 339-350
28. Molenaar, T. J., Michon, I., De Haas, S. A., Van Berkel, T. J., and Biessen, E. A. (2002) Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 293, 182-191
29. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., and Lenardo, M. J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354
30. Pearson, A. M., Rich, A., and Krieger, M. (1993) Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J. Biol. Chem. 268, 3546-3554
31. Melter, M., Reinders, M. E., Sho, M., Pal, S., Denton, M. D., Mukhopadhyay, D., and Briscoe, D. M. (2000) Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96, 3801-3808
32. Ditzel, H. J. (2004) The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol. Med. 10, 40-45
33. Van Kooten, C., Woltman, A. M., and Daha, M. R. (2000) Immunological function of tubular epithelial cells: the functional implications of CD40 expression. Exp. Nephrol. 8, 203-207
34. Richards, J. L., Abend, J. R., Miller, M. L., Chakraborty-Sett, S., and Whetter, L. E. (2003) A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells. Eur. J. Biochem. 270, 2287-2294
35. Zirlik, A., Bavendiek, U., Libby, P., MacFarlane, L., Jagielska, J., Ernst, S., Aikawa, M., Nakano, H., Tsitsikov, E., and Schonbeck, U. (2007) TRAF-1, 2, - 3, - 5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 1101-1107
36. Jalukar, S. V., Hostager, B. S., and Bishop, G. A. (2000) Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 164, 623-630
37. Baccam, M., Woo, S. Y., Vinson, C., and Bishop, G. A. (2003) CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J. Immunol. 170, 3099-3108
38. Pound, J. D., Challa, A., Holder, M. J., Armitage, R. J., Fanslow, W. C., Kikutani, H., Paulie, S., Gregory, C. D., and Gordon, J. (1999) Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Intl. Immunol. 11, 11-20
39. Page, A., Srinivasan, S., Singh, K., Russell, M., Deane, T., Sen, S., Stempora, L., Leopardi, F., Price, A. A., Strobert, E., Reimann, K. A., Kirk, A. D., Larsen, C. P., and Kean, L. S. (2012) CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am. J. Transplant. 12, 115-125